UVA1 Phototherapy in Acral Vitiligo

Not Applicable

Completed

• Conditions: Acral Vitiligo
• Interventions: Other: phototherapy

• Registration Number: NCT03378011
• Lead Sponsor: Cairo University

Brief Summary

evaluate the effect of UVA1 phototherapy in the treatment of acral vitiligo.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-11
• Primary Completion: 2016-11
• Study Completion: 2016-11
• Status Verified: 2017-12
• Study First Submitted: 2017-12-08
• Study First Submitted QC: 2017-12-17
• Last Update Submitted: 2017-12-17
• Study First Posted: 2017-12-19
• Last Update Posted: 2017-12-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Patients with acral vitiligo.
• Patients more than 12 years old.

Read More

Exclusion Criteria

• Patients less than 12 years old.
• Patients with any other skin diseases or autoimmune diseases.
• Patients taking medical treatment or phototherapy for vitiligo.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
UVA1 phototherapy	phototherapy	UVA1 phototherapy in acral vitiligo
Topical PUVA	phototherapy	Topical PUVA in acral vitiligo

Primary Outcome Measures

Name	Time	Method
effect of medium dose UVA1 phototherapy in treatment of acral vitiligo	1 year	effect of medium dose UVA1 phototherapy in treatment of acral vitiligo using point counting and vitiligo area severity index (VASI) score

Trial Locations

Locations (1)

Maha Fathy Elmasry; 🇪🇬 Cairo, Egypt